Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Nanyang Technological University
- RMIT UNIVERSITY
- Harvard University
- National University of Singapore
- Nature Careers
- Trinity College Dublin
- University of Oslo
- University of South-Eastern Norway
- ADELAIDE UNIVERSITY
- AbbVie
- Center for Drug Evaluation and Research (CDER)
- Institut de Recerca Biomèdica de Lleida (IRBLleida)
- Politécnico de Leiria
- RMIT University
- Singapore University of Technology & Design
- University of Agder
- University of Colorado
- University of Michigan
- University of Saskatchewan
- 9 more »
- « less
-
Field
-
models with hard-to-control outputs, we will focus on balancing data-based approaches with artists’ knowledge and search-based methods to achieve personalised and novel outputs. This position will have a
-
interdisciplinary pipelines to identify effective RNA drugs against human diseases: AI-driven RNA discovery – using AI agents to prioritize the therapeutic potential of human lncRNAs (supported by the NHLBI
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 18 days ago
(PROs) represent the only quantitative tool available to assess tolerability of oncologic agents under development, providing unique insights into the patient experience of symptomatic adverse events
-
World Asset Develop new agentic AI and large language models (LLMs) to support the algorithm designs for Real World Asset applications and ecosystems. Implement and test the Real World Asset framework
-
translational questions, including but not limited to drug efficacy and safety prediction, mechanism-of-action inference, biomarker discovery, causal or network-based modeling of biological systems, and drug
-
research projects in computer vision, machine learning, AI, and robotics. Projects may include physically-grounded AI guidance agents, modeling of multimodal data, and generative AI systems for situated
-
including multiple and embodied AI agents. Countering the current trends of very large models with hard-to-control outputs, we will focus on balancing data-based approaches with artists’ knowledge and search
-
but not limited to drug efficacy and safety prediction, mechanism-of-action inference, biomarker discovery, causal or network-based modeling of biological systems, and drug repurposing or design
-
for high resolution imaging, developing computational models of islet blood flow changes; characterizing and applying novel ultrasound contrast agents including molecular targeted agents; and use of contrast
-
Activity of CD8(+) T Cells. J Am Chem Soc.145(23) (2023) 12701-16. Research focus We aim to map T-cell interaction landscapes in complex immune microenvironments, understand how therapeutic agents act from